Brain Tumor Awareness Month: Providing Hope Through Research скачать в хорошем качестве

Brain Tumor Awareness Month: Providing Hope Through Research

In honor of Brain Tumor Awareness Month (#GoGrayInMay), Oncology Data Advisor Fellows Forum and Editorial Board members—Dr. Matthew Hadfield, Dr. Morana Vojnic, and Dr. Jethro Hu—sat down to share new and ongoing treatment directions and words of hope for patients who are diagnosed with brain tumors. Watch the video to hear more about: • The challenges in precision medicine and targeted therapy for brain tumors • Updates from the INDIGO trial, investigating vorasidenib for patients with residual/recurrent grade 2 IDH1/2-mutated glioma • The importance of molecular profiling for providing more information to determine treatment • The future of immunotherapy, vaccine-based therapy, and chimeric antigen receptor (CAR) T-cell therapy for brain tumors • The need to revise eligibility criteria of brain tumor clinical trials in order to make treatments more accessible • The power of patient advocacy groups and brain tumor support groups for sharing knowledge • The first thing that each of the speakers tell patients who are diagnosed with glioblastoma and the words of hope that they share “I don’t know exactly where the big breakthrough is going to come, but certainly there are a lot of immunotherapy, targeted therapy, and precision medicine approaches. Hopefully in the next generation of those approaches, we’ll be able to not just take the bare minimum of next-generation sequencing data, but we’ll be able to incorporate more data regarding the signaling involved in these tumors and understand how they evolve over time.” – Jethro Hu, MD “It’s a very challenging but very exciting field, especially given that the future seems much brighter than the past. We still have a long way to go, but there is some exciting data and hopefully some hope that we can provide for our patients.” – Morana Vojnic, MD, MBA